Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues
Eissler S, Bogner T, Nahrwold M, Sewald N (2009)
Chemistry - A European Journal 15(42): 11273-11287.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Einrichtung
Abstract / Bemerkung
Cryptophycins are a family of highly cytotoxic, cyclic depsipeptides. They display antitumour activity that is largely maintained for multidrug-resistant tumour cells. Cryptophycins are composed of four building blocks (units A-D) that correspond to the respective amino and hydroxy acids. A new synthetic route to unit A allows the selective generation of all four stereogenic centres in a short, efficient and reliable synthesis and contributes to an easier and faster synthesis of cryptophycins. The first two stereogenic centres are introduced by a catalytic asymmetric dihydroxylation, whereas the remaining two stereogenic centres are introduced with substrate control of diastercoselectivity. The stereogenic diol function also serves as the epoxide precursor. The approach was used to synthesise the native unit A building block as well as three para-alkoxymethyl analogues from which cryptophycin-52 and three analogous cryptophycins were prepared. Macrocyclisation of the seco-depsipeptides was based on ring-closing metathesis.
Stichworte
antitumor agents;
depsipeptides;
asymmetric synthesis;
natural;
total synthesis;
products
Erscheinungsjahr
2009
Zeitschriftentitel
Chemistry - A European Journal
Band
15
Ausgabe
42
Seite(n)
11273-11287
ISSN
0947-6539
eISSN
1521-3765
Page URI
https://pub.uni-bielefeld.de/record/1589822
Zitieren
Eissler S, Bogner T, Nahrwold M, Sewald N. Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues. Chemistry - A European Journal. 2009;15(42):11273-11287.
Eissler, S., Bogner, T., Nahrwold, M., & Sewald, N. (2009). Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues. Chemistry - A European Journal, 15(42), 11273-11287. https://doi.org/10.1002/chem.200901750
Eissler, Stefan, Bogner, Tobias, Nahrwold, Markus, and Sewald, Norbert. 2009. “Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues”. Chemistry - A European Journal 15 (42): 11273-11287.
Eissler, S., Bogner, T., Nahrwold, M., and Sewald, N. (2009). Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues. Chemistry - A European Journal 15, 11273-11287.
Eissler, S., et al., 2009. Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues. Chemistry - A European Journal, 15(42), p 11273-11287.
S. Eissler, et al., “Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues”, Chemistry - A European Journal, vol. 15, 2009, pp. 11273-11287.
Eissler, S., Bogner, T., Nahrwold, M., Sewald, N.: Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues. Chemistry - A European Journal. 15, 11273-11287 (2009).
Eissler, Stefan, Bogner, Tobias, Nahrwold, Markus, and Sewald, Norbert. “Efficient Synthesis of Cryptophycin-52 and Novel para-Alkoxymethyl Unit A Analogues”. Chemistry - A European Journal 15.42 (2009): 11273-11287.
7 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Octreotide Conjugates for Tumor Targeting and Imaging.
Figueras E, Martins A, Borbély A, Le Joncour V, Cordella P, Perego R, Modena D, Pagani P, Esposito S, Auciello G, Frese M, Gallinari P, Laakkonen P, Steinkühler C, Sewald N., Pharmaceutics 11(5), 2019
PMID: 31067748
Figueras E, Martins A, Borbély A, Le Joncour V, Cordella P, Perego R, Modena D, Pagani P, Esposito S, Auciello G, Frese M, Gallinari P, Laakkonen P, Steinkühler C, Sewald N., Pharmaceutics 11(5), 2019
PMID: 31067748
Novel unit B cryptophycin analogues as payloads for targeted therapy.
Figueras E, Borbély A, Ismail M, Frese M, Sewald N., Beilstein J Org Chem 14(), 2018
PMID: 29977395
Figueras E, Borbély A, Ismail M, Frese M, Sewald N., Beilstein J Org Chem 14(), 2018
PMID: 29977395
In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas.
Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N., ACS Omega 3(11), 2018
PMID: 30533574
Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N., ACS Omega 3(11), 2018
PMID: 30533574
Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.
Weiss C, Figueras E, Borbely AN, Sewald N., J Pept Sci 23(7-8), 2017
PMID: 28661555
Weiss C, Figueras E, Borbely AN, Sewald N., J Pept Sci 23(7-8), 2017
PMID: 28661555
Total synthesis and biological evaluation of fluorinated cryptophycins.
Weiß C, Bogner T, Sammet B, Sewald N., Beilstein J Org Chem 8(), 2012
PMID: 23209540
Weiß C, Bogner T, Sammet B, Sewald N., Beilstein J Org Chem 8(), 2012
PMID: 23209540
Drugs that target dynamic microtubules: a new molecular perspective.
Stanton RA, Gernert KM, Nettles JH, Aneja R., Med Res Rev 31(3), 2011
PMID: 21381049
Stanton RA, Gernert KM, Nettles JH, Aneja R., Med Res Rev 31(3), 2011
PMID: 21381049
New microtubule-inhibiting anticancer agents.
Chen SM, Meng LH, Ding J., Expert Opin Investig Drugs 19(3), 2010
PMID: 20141350
Chen SM, Meng LH, Ding J., Expert Opin Investig Drugs 19(3), 2010
PMID: 20141350
56 References
Daten bereitgestellt von Europe PubMed Central.
AUTHOR UNKNOWN, 0
Schwartz, J. Ind. Microbiol. 5(), 1990
Trimurtulu, J. Am. Chem. Soc. 116(), 1994
Golakoti, J. Am. Chem. Soc. 117(), 1995
Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV, Golakoti T, Patterson GM, Moore RE., J. Nat. Prod. 60(3), 1997
PMID: 9090872
Subbaraju GV, Golakoti T, Patterson GM, Moore RE., J. Nat. Prod. 60(3), 1997
PMID: 9090872
Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
Chaganty S, Golakoti T, Heltzel C, Moore RE, Yoshida WY., J. Nat. Prod. 67(8), 2004
PMID: 15332864
Chaganty S, Golakoti T, Heltzel C, Moore RE, Yoshida WY., J. Nat. Prod. 67(8), 2004
PMID: 15332864
AUTHOR UNKNOWN, 0
Kobayashi, Chem. Pharm. Bull. 42(), 1994
Kobayashi, Tetrahedron Lett. 35(), 1994
AUTHOR UNKNOWN, 0
Eissler, Synthesis (), 2006
The cryptophycins: their synthesis and anticancer activity.
Eggen M, Georg GI., Med Res Rev 22(2), 2002
PMID: 11857635
Eggen M, Georg GI., Med Res Rev 22(2), 2002
PMID: 11857635
Hamel, Curr. Med. Chem. 9(), 2002
Tius, Tetrahedron 58(), 2002
Nahrwold, Chim. Oggi 23(), 2008
AUTHOR UNKNOWN, 0
Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days.
Stevenson JP, Sun W, Gallagher M, Johnson R, Vaughn D, Schuchter L, Algazy K, Hahn S, Enas N, Ellis D, Thornton D, O'Dwyer PJ., Clin. Cancer Res. 8(8), 2002
PMID: 12171879
Stevenson JP, Sun W, Gallagher M, Johnson R, Vaughn D, Schuchter L, Algazy K, Hahn S, Enas N, Ellis D, Thornton D, O'Dwyer PJ., Clin. Cancer Res. 8(8), 2002
PMID: 12171879
Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.
Sessa C, Weigang-Kohler K, Pagani O, Greim G, Mora O, De Pas T, Burgess M, Weimer I, Johnson R., Eur. J. Cancer 38(18), 2002
PMID: 12460783
Sessa C, Weigang-Kohler K, Pagani O, Greim G, Mora O, De Pas T, Burgess M, Weimer I, Johnson R., Eur. J. Cancer 38(18), 2002
PMID: 12460783
A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer.
D'Agostino G, del Campo J, Mellado B, Izquierdo MA, Minarik T, Cirri L, Marini L, Perez-Gracia JL, Scambia G., Int. J. Gynecol. Cancer 16(1), 2006
PMID: 16445613
D'Agostino G, del Campo J, Mellado B, Izquierdo MA, Minarik T, Cirri L, Marini L, Perez-Gracia JL, Scambia G., Int. J. Gynecol. Cancer 16(1), 2006
PMID: 16445613
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.
Ravelli RB, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A, Knossow M., Nature 428(6979), 2004
PMID: 15014504
Ravelli RB, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A, Knossow M., Nature 428(6979), 2004
PMID: 15014504
AUTHOR UNKNOWN, 0
Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
Liang J, Moore RE, Moher ED, Munroe JE, Al-awar RS, Hay DA, Varie DL, Zhang TY, Aikins JA, Martinelli MJ, Shih C, Ray JE, Gibson LL, Vasudevan V, Polin L, White K, Kushner J, Simpson C, Pugh S, Corbett TH., Invest New Drugs 23(3), 2005
PMID: 15868377
Liang J, Moore RE, Moher ED, Munroe JE, Al-awar RS, Hay DA, Varie DL, Zhang TY, Aikins JA, Martinelli MJ, Shih C, Ray JE, Gibson LL, Vasudevan V, Polin L, White K, Kushner J, Simpson C, Pugh S, Corbett TH., Invest New Drugs 23(3), 2005
PMID: 15868377
Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
Al-Awar RS, Corbett TH, Ray JE, Polin L, Kennedy JH, Wagner MM, Williams DC., Mol. Cancer Ther. 3(9), 2004
PMID: 15367700
Al-Awar RS, Corbett TH, Ray JE, Polin L, Kennedy JH, Wagner MM, Williams DC., Mol. Cancer Ther. 3(9), 2004
PMID: 15367700
A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS, Ray JE, Schultz RM, Andis SL, Kennedy JH, Moore RE, Liang J, Golakoti T, Subbaraju GV, Corbett TH., J. Med. Chem. 46(14), 2003
PMID: 12825938
Al-Awar RS, Ray JE, Schultz RM, Andis SL, Kennedy JH, Moore RE, Liang J, Golakoti T, Subbaraju GV, Corbett TH., J. Med. Chem. 46(14), 2003
PMID: 12825938
Kobayashi, Chem. Pharm. Bull. 42(), 1994
AUTHOR UNKNOWN, 0
Total synthesis of cryptophycin analogues via a scaffold approach.
McCubbin JA, Maddess ML, Lautens M., Org. Lett. 8(14), 2006
PMID: 16805535
McCubbin JA, Maddess ML, Lautens M., Org. Lett. 8(14), 2006
PMID: 16805535
Tripathy, Tetrahedron Lett. 45(), 2004
Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
Magarvey NA, Beck ZQ, Golakoti T, Ding Y, Huber U, Hemscheidt TK, Abelson D, Moore RE, Sherman DH., ACS Chem. Biol. 1(12), 2006
PMID: 17240975
Magarvey NA, Beck ZQ, Golakoti T, Ding Y, Huber U, Hemscheidt TK, Abelson D, Moore RE, Sherman DH., ACS Chem. Biol. 1(12), 2006
PMID: 17240975
AUTHOR UNKNOWN, 0
Mast, Chem. Eur. J. 11(), 2005
Pousset, Tetrahedron 57(), 2001
Enantiospecific Total Synthesis of the Potent Antitumor Macrolides Cryptophycins 1 and 8.
Gardinier KM, Leahy JW., J. Org. Chem. 62(21), 1997
PMID: 11671811
Gardinier KM, Leahy JW., J. Org. Chem. 62(21), 1997
PMID: 11671811
AUTHOR UNKNOWN, 0
Synthesis of cryptophycin 52 using the sharpless asymmetric dihydroxylation: diol to epoxide transformation optimized for a base-sensitive substrate.
Liang J, Moher ED, Moore RE, Hoard DW., J. Org. Chem. 65(10), 2000
PMID: 10814209
Liang J, Moher ED, Moore RE, Hoard DW., J. Org. Chem. 65(10), 2000
PMID: 10814209
Kolb, Tetrahedron 48(), 1992
Kotoku, Tetrahedron Lett. 48(), 2007
Eissler, Synlett (), 2008
Short and efficient synthesis of cryptophycin unit A.
Eissler S, Nahrwold M, Neumann B, Stammler HG, Sewald N., Org. Lett. 9(5), 2007
PMID: 17284043
Eissler S, Nahrwold M, Neumann B, Stammler HG, Sewald N., Org. Lett. 9(5), 2007
PMID: 17284043
Wang, J. Org. Chem. 62(), 1997
Maryanoff, J. Am. Chem. Soc. 107(), 1985
Cheskis, Russ. Chem. Bull. 102(), 1993
Ragoussis, J. Chem. Soc. Perkin Trans. 1 (), 1998
AUTHOR UNKNOWN, 0
AUTHOR UNKNOWN, 0
Wang, Tetrahedron Lett. 33(), 1992
Harcken, Synlett (), 2001
Larcheveque, Tetrahedron 40(), 1984
3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors.
Weide T, Arve L, Prinz H, Waldmann H, Kessler H., Bioorg. Med. Chem. Lett. 16(1), 2005
PMID: 16236508
Weide T, Arve L, Prinz H, Waldmann H, Kessler H., Bioorg. Med. Chem. Lett. 16(1), 2005
PMID: 16236508
Ducry, Helv. Chim. Acta 82(), 1999
Inanaga, Bull. Chem. Soc. Jpn. 52(), 1979
Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene ligands.
Scholl M, Ding S, Lee CW, Grubbs RH., Org. Lett. 1(6), 1999
PMID: 10823227
Scholl M, Ding S, Lee CW, Grubbs RH., Org. Lett. 1(6), 1999
PMID: 10823227
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I., Proc. Natl. Acad. Sci. U.S.A. 83(12), 1986
PMID: 3459187
Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I., Proc. Natl. Acad. Sci. U.S.A. 83(12), 1986
PMID: 3459187
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity.
O'Brien J, Wilson I, Orton T, Pognan F., Eur. J. Biochem. 267(17), 2000
PMID: 10951200
O'Brien J, Wilson I, Orton T, Pognan F., Eur. J. Biochem. 267(17), 2000
PMID: 10951200
AUTHOR UNKNOWN, 0
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 19760734
PubMed | Europe PMC
Suchen in